Organization · Venture Capital
Flagship Pioneering
Flagship Pioneering is a venture creation firm based in Cambridge, Massachusetts, focused on inventing and funding biotechnology companies. Founded in 2000, it emphasizes a hands-on approach to building companies from scientific research and technological advancements.
Overview
What Flagship Pioneering does
What Flagship Pioneering is
Flagship Pioneering is a venture creation firm based in Cambridge, Massachusetts, focused on inventing and funding biotechnology companies. Founded in 2000, it emphasizes a hands-on approach to building companies from scientific research and technological advancements.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2000
- Approximate age
- About 26 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Flagship Pioneering elsewhere
Open the official website or a supported primary organization account.
Capability profile
Flagship Pioneering as a funder
Investment thesis
Flagship Pioneering originates first-in-category bioplatform companies from internally developed scientific hypotheses, focusing on transformative advancements in human health and sustainability.
Focus narrative
Flagship Pioneering invests primarily in the biotechnology sector, targeting early-stage companies that are developing transformative therapies and technologies. The firm emphasizes a hands-on approach, collaborating closely with scientists and entrepreneurs to nurture groundbreaking ideas that can lead to significant advancements in healthcare and sustainability.
Value beyond capital
Flagship Pioneering adds value to its portfolio companies through a comprehensive support system that includes scientific expertise, strategic partnerships, and access to capital. The firm acts not only as an investor but also as an inventor and company builder, facilitating the development of innovative solutions in biotechnology and healthcare.
Terms and economics
- Typical check
- $50,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Growth Equity
- Regions
- North AmericaEuropeAsia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 120
- Recorded notable exits
- Moderna, Tessera Therapeutics, and Generate:Biomedicines
Portfolio context
Flagship Pioneering has developed a diverse portfolio of companies, including: Moderna: A leader in mRNA medicines. Generate:Biomedicines: A generative biology platform. Tessera Therapeutics: Focused on gene-writing medicines. Inari Agriculture: Innovating in agriculture technology. Lila Sciences: Aiming to improve patient outcomes. Quotient Therapeutics: Developing transformative therapies. Serif Biomedicines: Launched in 2026 to develop Modified DNA medicines.
Common questions
What to know about Flagship Pioneering
Upseed classifies Flagship Pioneering under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.